Walmart Inc.
$872.87B- Market cap
- $838.83B
- Debt
- +$44.76B
- Cash
- −$10.73B
Capital structure 95% equity / 5% debt · EV / Revenue 1.22x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $838.83B · View financials
Snapshot Sep 10, 2026, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: WMT stock price at premium vs AMGN $105.73 current versus $73.38 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMGN's multiple
Implied fair value · at WMT's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Multiple discount
Higher P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 95% equity / 5% debt · EV / Revenue 1.22x
Capital structure 79% equity / 21% debt · EV / Revenue 6.86x · EV proxy / EBITDA proxy 17.71x
WMT carries the larger enterprise value at $872.87B against $252.25B; WMT trades on the lower EV / Revenue multiple (1.22x vs 6.86x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
WALMART INC. · implied price per share
Bear
$26.01
Base
$31.42
Bull
$38.87
Amgen Inc. · implied price per share
Bear
$121.60
Base
$161.79
Bull
$216.01
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TARGET CORP
WMT vs TGT
Costco Wholesale Corporation
WMT vs COST
Amazon.com, Inc.
WMT vs AMZN
CVS Health Corporation
WMT vs CVS
Walgreens Boots Alliance, Inc.
WMT vs WBA
DOLLAR GENERAL CORP
WMT vs DG
REGENERON PHARMACEUTICALS, INC.
WMT vs REGN
BIOGEN INC.
WMT vs BIIB
VERTEX PHARMACEUTICALS INC / MA
WMT vs VRTX
Gilead Sciences, Inc.
WMT vs GILD
Moderna, Inc.
WMT vs MRNA
Eli Lilly and Company
WMT vs LLY
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe WMT can sustain premium retail economics and defend a 40.8x P/E despite sub-AMGN growth and margins, then hold; otherwise, reduce exposure or avoid new buys because AMGN P/E comparison implies 44.2% downside and the valuation premium is not backed by stronger profitability.
WMT trades at 40.8x P/E versus AMGN at 23.7x, yet the implied price from AMGN P/E multiple is $64.62 versus WMT's current $115.77, suggesting a 44.2% downside under that lens. The gap is driven by WMT's much lower operating and net margins, even though its leverage is far lower than AMGN's.
Supporting Metrics